Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949230 · ClinicalTrials.gov registry record
A Retrospective Study of COVID-19 Treatments
A clinical trial of Covid19 and COVID-19 Respiratory Infection, sponsored by ProgenaBiome.
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04949230 is a study of Covid19 and COVID-19 Respiratory Infection that has completed, run by ProgenaBiome. The registered enrollment target is 300 participants, below the 2,699-participant average among 94 other Covid19 trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04949230, a study of Covid19 and COVID-19 Respiratory Infection, has completed, sponsored by ProgenaBiome.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.
Conditions Studied
Interventions
- OTHER No Intervention Used
Study Locations (1)
California
- Ginger Aurella - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2024-02-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04949230
The ClinicalTrials.gov registry entry for NCT04949230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,699-participant average among 94 other Covid19 trials with a reported enrollment target (89% lower). The listed sponsor is ProgenaBiome, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which No Intervention Used is the first listed.
NCT04949230 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04949230 about?
NCT04949230 is a clinical study titled "A Retrospective Study of COVID-19 Treatments". Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.
What is the current status of trial NCT04949230?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2021-02-19. Estimated completion is 2024-02-15.
What conditions does trial NCT04949230 study?
This clinical trial studies the following conditions: Covid19, COVID-19 Respiratory Infection, SARS-CoV2 Infection, COVID-19 Pneumonia, COVID-19 Acute Respiratory Distress Syndrome.
What interventions are being tested in trial NCT04949230?
The interventions under investigation include: No Intervention Used (OTHER).
Who is sponsoring clinical trial NCT04949230?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04949230 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.